These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12045159)
1. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Ridker PM Circulation; 2002 Jun; 105(22):2583-5. PubMed ID: 12045159 [No Abstract] [Full Text] [Related]
2. Inflammation, statins, and outcome after ischemic stroke. Di Napoli M; Papa F Stroke; 2001 Oct; 32(10):2446-7. PubMed ID: 11588346 [No Abstract] [Full Text] [Related]
3. New frontiers for cardiac risk assessment: C-reactive protein. Martin CM; Almond J Consult Pharm; 2006 Mar; 21(3):188-91, 195-6, 205-6. PubMed ID: 16573367 [TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Guijarro C Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039 [No Abstract] [Full Text] [Related]
6. Risk factors for non-haemorrhagic stroke and the effect of lipid-modifying therapy. Jackson PR J Hypertens; 2002 Dec; 20(12):2359-62. PubMed ID: 12473858 [No Abstract] [Full Text] [Related]
7. Inflammation, blood pressure, and stroke: an opportunity to target primary prevention? Muir KW Stroke; 2002 Dec; 33(12):2732-3. PubMed ID: 12468759 [No Abstract] [Full Text] [Related]
8. C-reactive protein, stroke, and statins. Angerio AD; Bialko MF; White BM Crit Care Nurs Q; 2007; 30(2):161-5. PubMed ID: 17356357 [TBL] [Abstract][Full Text] [Related]
9. High-Sensitivity C-Reactive Protein and Statin Initiation. Trpkovic A; Stanimirovic J; Rizzo M; Resanovic I; Soskic S; Jevremovic D; Isenovic ER Angiology; 2015 Jul; 66(6):503-7. PubMed ID: 25053677 [TBL] [Abstract][Full Text] [Related]
10. Statin use, albuminuria, and mortality risk: Re-evaluating C-reactive protein to albumin ratio in hypertensive patients based on NHANES data. Hung KC; Chao CT Nutr Metab Cardiovasc Dis; 2024 Aug; 34(8):2016-2017. PubMed ID: 38744583 [No Abstract] [Full Text] [Related]
11. Statins for stroke: the second story? Plutzky J; Ridker PM Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related]
12. Markers of inflammation and their clinical significance. Ballantyne CM; Nambi V Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493 [TBL] [Abstract][Full Text] [Related]
14. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease. Kones R Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829 [TBL] [Abstract][Full Text] [Related]
15. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Ridker PM Circulation; 2003 Sep; 108(12):e81-5. PubMed ID: 14504253 [No Abstract] [Full Text] [Related]
16. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341 [TBL] [Abstract][Full Text] [Related]
18. Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Panahi Y; Ahmadi Y; Teymouri M; Johnston TP; Sahebkar A J Cell Physiol; 2018 Jan; 233(1):141-152. PubMed ID: 28012169 [TBL] [Abstract][Full Text] [Related]
19. Dementia and statins. Birkenhäger WH; Wang JG; Staessen JA Lancet; 2001 Mar; 357(9259):880; author reply 880-1. PubMed ID: 11265971 [No Abstract] [Full Text] [Related]